Natural Biocon (India) Limited (BOM:543207)
India flag India · Delayed Price · Currency is INR
3.810
+0.110 (2.97%)
At close: Aug 14, 2026

Natural Biocon (India) Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
8.825.4583.48135.3412.544.82
Revenue Growth
-90.25%-69.51%-38.32%978.97%160.34%265.24%
Gross Profit
1.743.79.548.653.751.94
Operating Income
-1.9-0.40.612.262.480.89
Net Income
-1.9-0.40.451.531.790.66
Earnings Per Share
--0.020.020.130.160.06
EPS Growth
---84.62%-17.45%171.77%2297.39%

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.40.40.451.884.012.09
Total Debt
3.763.762.840.661.541.63
Net Cash (Debt)
-3.36-3.36-2.381.222.470.46
Net Cash Growth
----50.50%433.00%-
Net Cash Per Share
--0.17-0.110.110.220.04

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-0.2912.97-1.252.11.94
Capital Expenditures
--0.17----
Free Cash Flow
-0.1212.97-1.252.11.94
Free Cash Flow Growth
--99.05%--8.40%-40.14%

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
19.82%14.54%11.43%6.39%29.93%40.33%
Operating Margin
-21.62%-1.57%0.73%1.67%19.79%18.41%
Pretax Margin
-21.62%-1.57%0.71%1.66%19.69%18.24%
Profit Margin
-21.62%-1.57%0.53%1.13%14.28%13.68%
FCF Margin
-0.48%15.53%-0.92%16.77%40.29%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--857.3576.0729.46156.01
P/FCF Ratio
798.64681.2529.51-25.0852.97
PS Ratio
11.173.294.580.864.2121.34